Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide in Japanese Participants With Obesity Disease (SURMOUNT-J)
NCT04844918Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2021
- Primary completion
- Jun 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of tirzepatide in obesity, sponsored by Eli Lilly and Company. Started May 2021; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04844918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04844918.